Advanced in Interstitial Keratitis

Dr. Kenneth N. Sall

Ophthalmology
11423 187th St, Suite 200, 
Artesia, CA 
Advanced in Interstitial Keratitis
11423 187th St, Suite 200, 
Artesia, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Kenneth Sall is an Ophthalmologist in Artesia, California. Dr. Sall is rated as an Advanced provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Ocular Hypertension (OHT), Dry Eye Syndrome, Pigment-Dispersion Syndrome, Glaucoma, and Cataract Removal.

His clinical research consists of co-authoring 18 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article and participated in 3 clinical trials in the study of Interstitial Keratitis.

Specialties
Ophthalmology
Licenses
Ophthalmology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

11423 187th St, Suite 200, Artesia, CA 90701

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, Double-Masked, Randomized, Controlled Trial of KPI-121 in Postsurgical Inflammation
A Phase III, Double-Masked, Randomized, Controlled Trial of KPI-121 in Postsurgical Inflammation
Enrollment Status: Completed
Publish Date: January 29, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
A Phase 3, Double-Masked, Randomized, Controlled Study of KPI-121 0.25% Ophthalmic Suspension Compared to Vehicle in Subjects With Dry Eye Disease
Enrollment Status: Completed
Publish Date: January 05, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain
A Phase 3, Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Efficacy of KPI-121 1.0% Ophthalmic Suspension in Subjects With Postsurgical Inflammation and Pain
Enrollment Status: Completed
Publish Date: December 16, 2020
Intervention Type: Drug
Study Phase: Phase 3
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Randomized, Double-Masked, Parallel Group Study of P-321 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye Disease Assessing Safety and Efficacy Over 28 Days
Enrollment Status: Terminated
Publish Date: October 11, 2018
Intervention Type: Drug
Study Phase: Phase 2
A Single Arm, Multicenter, Open-Label Study Designed to Evaluate Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
A Single Arm, Multicenter, Open-Label Study Designed to Evaluate Acute Tear Production Following Single Use of the Oculeve Intranasal Neurostimulator
Enrollment Status: Completed
Publish Date: October 25, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

18 Total Publications

A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium.
A Phase IIa Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CBT-001 Ophthalmic Solution in Patients With Primary or Recurrent Pterygium.
Journal: Ophthalmology science
Published: August 08, 2023
Similar Doctors
Distinguished in Interstitial Keratitis
Dr. Sumit S. Garg
Ophthalmology
Distinguished in Interstitial Keratitis
Dr. Sumit S. Garg
Ophthalmology

Regents Of The University Of California

101 The City Dr S, 
Orange, CA 
 (12.5 miles away)
714-456-8068
Languages Spoken:
English
See accepted insurances

Sumit Garg is an Ophthalmologist in Orange, California. Dr. Garg is rated as a Distinguished provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Interstitial Keratitis, Meibomianitis, Cataract, Corneal Transplant, and Cataract Removal.

Distinguished in Interstitial Keratitis
Dr. Olivia L. Lee
Ophthalmology
Distinguished in Interstitial Keratitis
Dr. Olivia L. Lee
Ophthalmology

Regents Of The University Of California

101 The City Dr S, 
Orange, CA 
 (12.5 miles away)
714-456-8068
Languages Spoken:
English
See accepted insurances

Olivia Lee is an Ophthalmologist in Orange, California. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Interstitial Keratitis. Her top areas of expertise are Pterygium, Interstitial Keratitis, Amebiasis, Trabeculectomy, and Corneal Transplant.

Distinguished in Interstitial Keratitis
Dr. Arkady B. Kagan
Ophthalmology
Distinguished in Interstitial Keratitis
Dr. Arkady B. Kagan
Ophthalmology
5455 Wilshire Blvd, 
Los Angeles, CA 
 (20.3 miles away)
323-937-2269
Languages Spoken:
English
See accepted insurances

Arkady Kagan is an Ophthalmologist in Los Angeles, California. Dr. Kagan is rated as an Advanced provider by MediFind in the treatment of Interstitial Keratitis. His top areas of expertise are Interstitial Keratitis, Glaucoma, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sall's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile